CD44 and non-small cell lung carcinoma: In addition, sorting non-small cell lung cancer (NSCLC) cells using the cancer stem cell marker CD44 revealed elevated GTP-RALA levels in the CD44high putative stem cell population compared to CD44low populations [167].